NCT05784753Recruiting
HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection Fraction
HEART (Heart Failure Exercise and Resistance Training) Camp Connect: Promoting Adherence to Exercise in Adults With Heart Failure With Preserved Ejection Fraction
Source: ClinicalTrials.gov · Last updated 16 Jan 2026
Brief summary (registry, in English)
The goal of this study is to learn more about patients with heart failure with preserved ejection fraction (HFpEF) and exercise. Investigators want to see if meeting with a coach in person or by video conference will help these patients exercise, feel better, and change markers in their blood. Participants will be randomly placed in one of three groups for 18 months. All groups will have access to a fitness center and be given a watch and heart rate monitor to wear during exercise. The usual care group (control group) will have access to exercise videos via the medical fitness center and will not meet with a coach. The HEART Camp group will exercise and meet with their coach in-person at the medical fitness center. The HEART Camp Connect group will have access to exercise videos via the medical fitness center and will meet with their coach via videoconferencing. All participants will take part in an exercise test and study training prior to being randomized. At four data collection time points, participants will wear an activity monitor for 7 days each, have their blood drawn, and answer questions related to heart failure and exercise. Participants will also wear a heart rate monitor when they exercise and fill out a daily exercise diary.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 2 Mar 2023
- Start date
- 20 Nov 2023
- Primary completion date
- Feb 2028
- Lead sponsor
- University of Nebraska
- Diseases
- Heart failure
- NCT number
- NCT05784753
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 20 Nov 2023 to the primary completion date, Feb 2028
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Myocardial infarction, coronary artery bypass graft, or biventricular pacemaker in prior 6 weeks
Other illness
- Life-limiting illness precluding study completion
- Clinical evidence of decompensated heart failure
- Unstable angina or marked shortness of breath on exertion at less than 2 metabolic equivalents
- Orthopedic or neuromuscular disorders preventing aerobic exercise
Other
- Cardiopulmonary exercise test results that preclude safe exercise
- Unwilling/unable to complete pre-randomization procedures
- Pregnancy
- Implantable cardioverter defibrillator
Who the study is looking for
- Diagnosis of heart failure with an ejection fraction greater than or equal to 50
- Echocardiogram in prior 24 months
- Stable pharmacologic therapy in the past 30 days
- Any of the following evidence to confirm HFpEF - Score\< 6 on Heavy Hypertensive Atrial Fibrillation, Pulmonary Hypertension, Elder, Filling Pressure algorithm, invasive hemodynamic evidence of HFpEF(i.e., elevated pulmonary wedge pressure), or a confirmed clinical diagnosis of HFpEF
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Virginia Coordinator of this site? Confirm its status | Charlottesville | United States | Not yet recruiting |
| Henry Ford Health System Coordinator of this site? Confirm its status | Detroit | United States | Recruiting |
| University of Nebraska Medical Center Coordinator of this site? Confirm its status | Omaha | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.